Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity,Journal of Addictive Diseases

当前位置： X-MOL 学术 › Journal of Addictive Diseases › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
Journal of Addictive Diseases ( IF 2.065 ) Pub Date : 2024-03-31 , DOI: 10.1080/10550887.2024.2327739
Zhenhao Shi ₁ , Daniel D. Langleben ₁ , David Rott ₂ , Mark Albanese _{3,

4} , Igor Elman ₃

Affiliation

Consuming opioid agonists is a risk factor for cardiovascular disease particularly in intravenous heroin users. The monthly injectable extended-release opioid antagonist, naltrexone (XR-NTX) is an ...

中文翻译：